Sub Cat | Epitope | Isotype | Application | Affinity | |
---|---|---|---|---|---|
V3S-1124-YC258 | IgG1 | ELISA; WB | 0.182 nM-0.463 nM | ||
V3S-0622-YC31 | Aβ 1-40 | IgG | ELISA; WB; Inhib; FuncS | ||
V3S-0622-YC32 | Aβ 1-42 | IgG | ELISA; Inhib; WB | ||
V3S-0622-YC33 | Aβ 1-42 | IgG | ELISA; Inhib; WB | ||
V3S-0522-YC490 | Aβ 19-22 | IgG1 kappa | ELISA; WB; IP; FuncS | ||
V3S-0522-YC492 | Aβ 3-7 | IgG1 | ELISA; FuncS | 23.3 nM | |
V3S-0522-YC7262 | IgG2 kappa | WB; FuncS | |||
V3S-1022-YC1384 | IgG | Cyt | |||
V3S-1022-YC1388 | IgG | Inhib | |||
V3S-1022-YC2077 | IgG | ELISA; DB; IP | 55 nM | ||
V3S-1022-YC3854 | Located in the sequence: DAEFRHDSGYEVHHQK | IgM | ELISA; Inhib | ||
V3S-1022-YC3856 | Located in the sequence: DAEFRHDSGYEVHHQK | IgM | IHC; ELISA; Inhib |
Description | The humanized IgG/k versions of the murine mAb against beta-amyloid polypeptide were created. The humanized mAb was produced by transient transfections in CHO-S or HEK293F cells. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | Human |
Affinity | The KD ranges, 0.182 nM-0.463 nM, were determined using 2:1 kinetics of binding of analyte (BSA-cSNK). |
Isotype | IgG1 |
Expression Species | HEK293F or CHO |
Conjugation | None |
Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
Endotoxin | <1 EU/mg |
Purification | Protein A affinity purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
Application | ELISA; WB |
Application Notes | ELISA Assay of Humanized 5E3 (hu5E3) mAb An ELISA was used to test the binding of hu5E3 against cSNK-BSA peptide. The ELISA plate was coated with antigen (Ag), 1 μg/well of cSNK-BSA. The wells were blocked with 5% skim milk then probed with serially diluted the mAbs (0.01 μg/mL to 5 μg/mL) and binding was detected with a commercial goat anti-human HRP conjugate antibody. The plate was read at 450 nm. Western Blot Analysis of Humanized 5E3 (hu5E3) mAb A 4-12% gradient SDS-PAGE gel was run with cSNK-BSA. The gel was then transferred to a nitrocellulose membrane. The next day the mAbs were diluted to 2 μg/ml to 5 μg/ml depending on the antibody, and used to probe the membrane at room temperature (RT). The membranes were then probed with anti-human IgG-HRP. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | APP |
Alternative Name | AAA; AD1; PN2; ABPP; APPI; CVAP; ABETA; PN-II; preA4; CTFgamma; Amyloid-beta precursor protein; Amyloid-beta A4 protein; Alzheimer disease amyloid protein; Amyloid beta (A4) precursor protein; Amyloid beta A4 protein; Amyloid precursor protein; Beta-amyloid peptide; Beta-amyloid peptide(1-40); Beta-amyloid peptide(1-42); Beta-amyloid precursor protein; Cerebral vascular amyloid peptide; Peptidase nexin-II; Protease nexin-II; Testicular tissue protein Li 2 |
Gene ID | 351 |
UniProt | P05067 |
Research Area | Neuroscience |